Iron overload gene linked to colon cancer:
This article was originally published in Clinica
Executive Summary
Genetic mutations that are associated with hereditary haemochromatosis (HFE), or iron overload, increase the risk of colon cancer by 40%, say US researchers. A 1,300-patient study found that the frequency of the mutations in individuals' HFE genes was much greater in patients with colon cancer, compared with cancer-free people. A test panel of markers for the mutations could help identify those patients who would benefit from intensified colorectal cancer screening, say the study authors, whose findings appear in the Journal of the National Cancer Institute (January 15).
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.